Trial Profile
Clinical Trials Insight: 700055430
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 16 Apr 2010
Price :
$35
*
At a glance
- Drugs WP 1303 Worg Pharmaceuticals (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Sponsors Apitope Technology
- 30 Jan 2008 New trial record.